3billion's technologies for patients
with rare diseases

From Variant Interpretation Technology

to Drug Discovery

Learn more about 3billion’s research and development.

EVIDENCE

EVIDENCE is 3billion’s automated genetic variant interpretation system. It categorizes variants fast and accurately accordingly to their pathogenicity, providing a consistent diagnosis result.
Learn more

3Cnet

3Cnet is 3billion’s variant pathology prediction tool. It exceeds conventional AI-based pathogenic prediction tools in prediction accuracy.
Learn more

Reanalysis

3billion has built an automated reanalysis pipeline. We reanalyze inconclusive and negative cases on a daily basis, based on the newest symptom-variant research.
Learn more

Drug discovery

MIN-T is 3billion’s AI drug discovery system. We are committed to accelerating and streamlining the development of orphan drugs using our proprietary technology.
Learn more